Register for email alerts and news feeds:
This journal | BMJ Group
rss
Postgraduate Medical Journal 2005;81:194-195; doi:10.1136/pgmj.2003.018267
© 2005 BMJ Publishing Group Ltd and The Fellowship of Postgraduate Medicine.
Postgraduate Medical Journal 2005;81:194-195
© 2005 Fellowship of Postgraduate Medicine

ADVERSE DRUG REACTION

A woman who couldn’t speak: report of methotrexate neurotoxicity

P Szawarski1, C S Chapman2

1 Respiratory Medicine, Glenfield General Hospital, Leicester, UK
2 Haematology Department, Leicester Royal Infirmary, Leicester, UK

Correspondence to:
Correspondence to:
Dr C S Chapman
Haematology Department, Sandringham Building, Leicester Royal Infirmary, Infirmary Square, Leicester LE1 5WW, UK; claire.chapman{at}uhl-tr.nhs.uk

The association between methotrexate therapy and idiosyncratic neurological complications is well recognised in children. This case illustrates the importance of considering the diagnosis of methotrexate toxicity in an adult patient with behavioural and speech disturbances, who received it by intrathecal route only and in whom the only indicator was an abnormal electroencephalographic study

Abbreviations: ALL, acute lymphoblastic leukaemia; MRI, magnetic resonance imaging

Keywords: acute lymphoblastic leukaemia; aphasia; methotrexate


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.